A MULTICENTRE, PROSPECTIVE, NON-INTERVENTIONAL SINGLE-ARM STUDY INVESTIGATING THE IMPACT OF ONCE-DAILY ORAL SEMAGLUTIDE IN A REAL-WORLD ADULT POPULATION WITH TYPE 2 DIABETES IN MEXICO